Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
BPI Contributor
April 1, 2022
20 Min View
Date: Apr 1, 2022
Duration: 20 Min
Already have an account?
BioProcess Insider’s State of the Industry takes a deeper look into the recent business news affecting the biomanufacturing industry, picking apart the numbers and highlighting potential trends.
With a panel of industry experts, editor Dan Stanton discusses recent mergers and acquisitions in the bioprocess space, bottlenecks within the manufacturing sector, the continued head- and tailwinds COVID-19 is placing on businesses, and the evolution of the cell and gene therapy landscape and what that means for supply chains.
Panelists:
Frank Orlowski, Director of Business Development, Latham Biopharm Group
Steven Lee, CEO, Eden Biologics
Joe Scott, Vice President, Supply Chain Operations, Avid Bioservices
About the Author
You May Also Like
Mar 18 - Mar 21, 2025
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More
